These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 1824297)
1. Role of cholecystokinin in postprandial and vagally stimulated duodenal and gallbladder motility in dogs. Thor P; Laskiewcz J; Maczka M; Konturek SJ J Physiol Pharmacol; 1991 Dec; 42(4):381-8. PubMed ID: 1824297 [TBL] [Abstract][Full Text] [Related]
2. Relationship between gallbladder bile concentration and motility in conscious dogs: role of cholecystokinin. Muramatsu S; Sonobe K; Mizumoto A; Yamada T; Itoh Z Peptides; 1997; 18(1):111-8. PubMed ID: 9114460 [TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs. Thor P; Laskiewicz J; Konturek P; Konturek SJ Am J Physiol; 1988 Oct; 255(4 Pt 1):G498-504. PubMed ID: 3177646 [TBL] [Abstract][Full Text] [Related]
4. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide. Romański KW J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220 [TBL] [Abstract][Full Text] [Related]
5. Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors in the vagal pathway and gallbladder in the dog. Sonobe K; Sakai T; Satoh M; Haga N; Itoh Z Regul Pept; 1995 Dec; 60(1):33-46. PubMed ID: 8747782 [TBL] [Abstract][Full Text] [Related]
7. [Regulative effect of leptin on gastric motility: experiment with conscious rats]. Wang LJ; Zhou L; Yuan B; Wang L Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2266-70. PubMed ID: 17064572 [TBL] [Abstract][Full Text] [Related]
8. Endogenous CCK is not involved in the regulation of interdigestive gastrointestinal and gallbladder motility in conscious dogs. Mizumoto A; Ueki S; Ohtawa M; Itoh Z Regul Pept; 1992 Oct; 41(3):249-56. PubMed ID: 1438992 [TBL] [Abstract][Full Text] [Related]
9. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo. Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808 [TBL] [Abstract][Full Text] [Related]
10. Relation between duodenal alkaline secretion and motility in fasted and sham-fed dogs. Konturek SJ; Thor P Am J Physiol; 1986 Nov; 251(5 Pt 1):G591-6. PubMed ID: 3777166 [TBL] [Abstract][Full Text] [Related]
11. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584 [TBL] [Abstract][Full Text] [Related]
12. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist. Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283 [TBL] [Abstract][Full Text] [Related]
13. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism. Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by CCK of ascending contraction elicited by mucosal stimulation in the duodenum of the rat. Giralt M; Vergara P Neurogastroenterol Motil; 2000 Apr; 12(2):173-80. PubMed ID: 10877605 [TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and the interrelation between intestinal motility and pancreatic secretion in fasted and fed dogs. Maczka M; Thor P; Bilski J; Konturek SJ J Physiol Pharmacol; 1994 Jun; 45(2):285-98. PubMed ID: 7949237 [TBL] [Abstract][Full Text] [Related]
18. Ovine model for clear-cut study on the role of cholecystokinin in antral, small intestinal and gallbladder motility. Romański KW Pol J Pharmacol; 2004; 56(2):247-56. PubMed ID: 15156076 [TBL] [Abstract][Full Text] [Related]
19. [Cholecystokinin and its antagonists: effects on digestive motility]. Bruley des Varannes S; Cloarec D; Dubois A; Galmiche JP Gastroenterol Clin Biol; 1991; 15(10):744-57. PubMed ID: 1816015 [No Abstract] [Full Text] [Related]